CVS Health (CVS) Form 3 CVS HEALTH / Sreekanth K Chaguturu ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Chaguturu Sreekanth K

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RI 02895

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/11/2022

3. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP and Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock (RSU)(1)	996	I	RSU
Common Stock (RSU)(2)	354	I	RSU
Common Stock (RSU)(3)	2,154	I	RSU
Common Stock (RSU)(4)	1,258	I	RSU
Common Stock (RSU)(5)	2,085	I	RSU
Common Stock (RSU)(6)	2,776	I	RSU
Common Stock (RSU)(7)	6,182	I	RSU
Common Stock	2,342.7803	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	11/29/2020(8)	11/29/2029	Common Stock	5,952	75.27	I	Option
Stock Option	04/01/2021(9)	04/01/2030	Common Stock	9,579	58.34	I	Option
Stock Option	04/01/2022(10)	04/01/2031	Common Stock	9,502	74.3	I	Option
Stock Option	04/01/2023(11)	04/01/2032	Common Stock	12,993	101.09	I	Option

Explanation of Responses:

1. Consists of Restricted Stock Units (RSUs) awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date.

2. Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse on 2/28/2023.

3. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.

4. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.

5. Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse in two equal installments beginning 2/26/2023.

6. Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse in three equal installments beginning 4/1/2023.

7. Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in four equal installments beginning 4/1/2023.

8. Option becomes exercisable in four equal annual installments, commencing 11/29/2020.

9. Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

10. Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

11. Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

	/s/ Sreekanth K. Chaguturu	05/19/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.